SCHEMBL22353144

SCHEMBL22353144

Cc1nc(-c2ccc(NC(=O)Cc3ccccc3Cl)cc2[S+](N)[O-])cs1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ CLK2 P49760 1/20 0.47
▸ PRKX P51817 1/20 0.47
▸ CAMK2D Q13557 1/20 0.47
▸ PKN2 Q16513 1/20 0.47
▸ CLK4 Q9HAZ1 1/20 0.47
▸ STK17A Q9UEE5 1/20 0.47
▸ LMNA P02545 3/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ KCNJ5 P48544 5/20 0.45
▸ KCNJ3 P48549 5/20 0.45
▸ KCNJ6 P48051 2/20 0.45
▸ ROCK2 O75116 3/20 0.44
▸ ROCK1 Q13464 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ ANO1 Q5XXA6 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22353046 0.89 ROCK2 (0.48) NPC1RAB9ACLK2PRKXCAMK2D
SCHEMBL19577054 0.86 CLK2 (0.44) NPC1RAB9ACLK2PRKXCAMK2D
SCHEMBL29716971 0.83 P2RX4 (0.56) LMNAKCNJ5KCNJ3KCNJ6ALDH1A1
SCHEMBL19576958 0.83 P2RX4 (0.56) LMNAKCNJ5KCNJ3KCNJ6ALDH1A1
SCHEMBL22353212 0.80 KCNJ5 (0.49) CLK2PRKXCAMK2DPKN2CLK4
SCHEMBL22353164 0.79 KCNJ5 (0.49) CLK2PRKXCAMK2DPKN2CLK4
SCHEMBL19576914 0.79 ROCK2 (0.46) CLK2PRKXCAMK2DPKN2CLK4
SCHEMBL22353216 0.76 ROCK2 (0.50) CLK2PRKXCAMK2DPKN2CLK4
SCHEMBL22353039 0.76 ROCK2 (0.44) NPC1RAB9ACLK2PRKXCAMK2D
SCHEMBL22894150 0.76 KCNJ5 (0.55) CLK2PRKXCAMK2DPKN2CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3458443-B1 AROMATIC SULFONAMIDE DERIVATIVES Bayer Pharma AG (DE) 2020-08-19 — — EP disclosed
Send feedback